Affiliation:
1. FSBI “Zakusov Institute of Pharmacology”
Abstract
The review presents the results of studies on the pharmacokinetics, metabolism, and bioavailability of new neurotropic dipeptide cyclo-Lprolilglycine (CPG) and their pharmacological activity. It was shown that the pharmacologically active metabolite of the nootropic drug noopept cyclo-Lprolilglycine (CPG) is an endogenous dipeptide, it is a fragment of the terminal Tripeptide of the insulin-like nerve growth factor IGF-1. Much attention is paid both in Russia and abroad to the development of modified CPG analogues with improved pharmacokinetic properties, enzymatically more stable, better penetrating the BBB, and highly effective when used in micromolar doses. CPG shows neuroprotective activity in ischemic-hypoxic and other brain injuries, in addition, it has a complex of other pharmacological effects and therefore CPG can be considered not only as a potential drug, but also as a basic structure for the development of new neurotropic drugs – analogs of CPG with improved pharmacokinetic properties, greater enzymatic resistance and higher bioavailability for the central nervous system.
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science
Reference25 articles.
1. Boyko SS, Zherdev VP, Gudasheva ТA, Ostrovskaya RU еt al. Pharmacokinetics of dipeptide analog pyracetame wich nootropic activity GWS-111 and its main metabolites. Experimental and Clinical Pharmacology. 1997;72(2):3–6. (In Russ).
2. Boyko SS, Zherdev VP, Gudasheva ТA еt al. Pharmacokinetics of new potencial dipeptide nootrope GWS-111 and its main metabolites in rat brain. Khimico-Farmatsevicheskii Zhurnal. 2001;35(9):11–13. (In Russ). doi: 10.1023/A^10140824082406443.
3. Gudasheva ТA, Boyko SS, Akparov VKh еt al. Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo-prolylglycine in rat brain. FEBS Leters. 1996;391(1-2):149–152. DOI: 10.1016/0014-5793(96)00722-3.
4. Gudasheva ТA, Boyko SS, Ostrovskaya RU, еt al. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and similarlity to endogenous neuropeptide cyclo-prolylglycine. Eur J Drug Metab Pharmacokinet. 1997;22(3):245–252. DOI: 10.1007/BF03189814.
5. J Guan. Insulin-Like Growth Factor-1 and its Derivatives Potential Pharmaceutical Application for Ischemic Brain Injury. Recent Pat CNS Drug Discov. 2008;3(2):112–117. DOI: 10.2174/157488908784534630.